FDA Issues Warning Letter to Mark S. Dacey, M.D.
February 11, 2026
February 11, 2026
WASHINGTON, Feb. 11 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Mark S. Dacey, M.D. from the Center for Drug Evaluation and Research:
* * *
Recipient: Mark S. Dacey, M.D., 425 South Cherry Street, Suite 907, Denver, CO 80246-1242, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
FDA Ref. No.: 26-HFD- . . .
* * *
Recipient: Mark S. Dacey, M.D., 425 South Cherry Street, Suite 907, Denver, CO 80246-1242, United States
Issuing Office: Center for Drug Evaluation and Research (CDER), United States
WARNING LETTER
FDA Ref. No.: 26-HFD- . . .
